Oxford Biomedica raises £60m to bolster US capacity.
Oxford Biomedica has raised £60m via a share placing and subcription to expand its US operations, the gene and cell therapy company announced on Friday.
Oxford Biomedica
15 August 2025 09:22:02
Source: Sharecast
A total of 12.21m shares were placed at a price of 431p each, slightly below Thursday's closing price of 439.50p, while certain existing shareholders subscribed for 1.71m shares.
In total, the placing and subscription represented 13.1% of the issued share capital of the company.
OXB said the net proceeds from the fundraising would go towards expanding its US commercial-scale capacity and advancing process quality, productivity and yields.
"This will allow the Company to address growing client demand including visible near and medium-term opportunities across all clinical phases, including late-stage and commercial supply," OXB said.
Shares were up 1.9% at 447.83p by 0919 BST.
N/A
ISIN:
N/A
Exchange: N/A
Sell:
N/A
Buy:
N/A
Change:
Date:
Prices delayed by at least 15 minutes
Compare our accounts
If you're looking to grow your money over the longer term (5+ years), we have a range of investment choices to help.
Halifax is not responsible for the content and accuracy of the Markets News articles. We may not share the views of the author. Understand the risks, please remember the value of your investment can go down as well as up and you may not get back the full amount you invest. We don't provide advice so if you are in any doubt about buying and selling shares or making your own investment decisions we recommend you seek advice from a suitably qualified Financial Advisor. Past performance is not a guide to future performance.
